Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Id2 is a natural inhibitor of the basic helix-loop-helix transcription factors and the retinoblastoma tumor suppressor protein. Active Id2 prevents differentiation and promotes cell-cycle progression and tumorigenesis in the nervous system. A key event that regulates Id2 activity during differentiation is translocation from the nucleus to the cytoplasm. Here we show that the actin-associated protein
enigma homolog
(
ENH
) is a cytoplasmic retention factor for Id2.
ENH
contains three LIM domains, which bind to the helix-loop-helix domain of Id proteins in vitro and in vivo.
ENH
is up-regulated during neural differentiation, and its ectopic expression in
neuroblastoma
cells leads to translocation of Id2 from the nucleus to the cytoplasm, with consequent inactivation of transcriptional and cell-cycle-promoting functions of Id2. Conversely, silencing of
ENH
by RNA interference prevents cytoplasmic relocation of Id2 in
neuroblastoma
cells differentiated with retinoic acid. Finally, the differentiated neural crest-derived tumor ganglioneuroblastoma coexpresses Id2 and
ENH
in the cytoplasm of ganglionic cells. These data indicate that
ENH
contributes to differentiation of the nervous system through cytoplasmic sequestration of Id2. They also suggest that
ENH
is a restraining factor of the oncogenic activity of Id proteins in neural tumors.
...
PMID:The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. 1654 80